Mouse Anti-MLF2 (AA 1-248) Recombinant Antibody (CBFYM-2285) (CBMAB-M2470-FY)

Fang, D., Hu, H., Zhao, K., Xu, A., Yu, C., Zhu, Y., ... & Mei, Y. (2023). MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis. Advanced Science, 10(26), 2303336.

Ogunleye, A. J., Romanova, E., & Medvedeva, Y. A. (2021). Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia. F1000Research, 10.

Yang, J., Cao, D., Zhang, Y., Ou, R., Yin, Z., Liu, Y., ... & Fei, J. (2020). The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis. Cancer Gene Therapy, 27(1-2), 98-107.

Huang, D., Liu, C., Sun, X., Sun, X., Qu, Y., Tang, Y., ... & Tong, T. (2020). CRL4DCAF8 and USP11 oppositely regulate the stability of myeloid leukemia factors (MLFs). Biochemical and Biophysical Research Communications, 529(2), 127-132.

Rampello, A. J., Laudermilch, E., Vishnoi, N., Prophet, S. M., Shao, L., Zhao, C., ... & Schlieker, C. (2020). Torsin ATPase deficiency leads to defects in nuclear pore biogenesis and sequestration of MLF2. Journal of Cell Biology, 219(6).

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols